Evaluating the Bioequivalence of HIP1302, HGP1406
Clinical trial NCT02545829 · COMPLETED
Trial details
- NCT number
- NCT02545829
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2015-10-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.